Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Umbilical cord mesenchymal stem cell therapy in end-stage liver disease
ChiCTR-ONRC-13004581Phase 2Completed
- Sponsor
- Jinan Infectious Disease Hospital
- Start
- Jun 2014
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label trial of human umbilical cord mesenchymal stem cells in hepatic disease and Cirrhosis (2 arms), sponsored by Jinan Infectious Disease Hospital. Primary endpoints: Incidence of liver cancer, Adverse events and 8 more. Started Jun 2014; status: completed.
02
Drugs
human umbilical cord mesenchymal stem cells
03
Conditions
hepatic diseaseCirrhosis
Beyond the preview
Go deeper on ChiCTR-ONRC-13004581.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-ONRC-13004581.